Observational study explores immunotherapy targets in gastric cancer, suggesting future advancements for patient outcomes.
TLSs represent promising prognostic indicators and potential targets for immunotherapy in gastric cancer. However, several challenges remain, and further research is needed to better understand their mechanisms and clinical applications, ultimately contributing to improved survival and quality of life in patients with advanced gastric cancer.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: